Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Crest Nicholson warns on profits but points to improving conditions

(Sharecast News) - Home construction company Crest Nicholson has delivered a profit warning as a result of higher-than-expected costs as it announced an additional one-off charge from a legal claim. The group said that adjusted pre-tax profit for 2023 is now expected to be £41m, lower than the £45-50m range given in November. That would mark a 70% reduction from £137.8m in 2022.

The company's zero-margin scheme, Brightwells Yard in Farnham, was expected to record £11m of costs in the second half as work continued on completing certain legacy sites. However, "further additional costs have been identified" following a review, it said.

In addition, Crest Nicholson said it now expects to take a £13m one-off, non-cash hit due to a recently received legal claim relating to a low-rise apartment scheme which was damaged by fire in 2021.

"The group is addressing this claim diligently and efficiently and will provide further details in our preliminary results," the company said ahead of its annual report on 23 January.

Positively, Crest Nicholson said it is seeing a "more constructive backdrop for house buyers and the wider housing market" in 2024 as a result of the recent reduction in mortgage rates.

"Although it is too early to gauge customer behaviour, we have been encouraged by an increase in customer interest levels and inquiries this calendar year."

Share this article

Related Sharecast Articles

Entain reprices two term loans, revises interest cost outlook
(Sharecast News) - Betting and gambling giant Entain announced the successful repricing of two of its existing 'Term Loan B' loans on Monday, along with the pricing and allocation of fungible add-ons, in a bid to optimise its financial position.
Oxford Biomedica confident as it moves away from vaccine era
(Sharecast News) - Cell and gene therapy contract development and manufacturing organisation (CDMO) Oxford Biomedica reported stability in its core business on Monday, with a small increase in full-year core revenue for 2023, despite a 36% decrease in total revenue to £89.5m.
N Brown chairman Ron McMillan to retire
(Sharecast News) - N Brown said on Monday that chairman Ron McMillan will be retiring and stepping down from the board with effect from 30 April for personal reasons.
McCarthy out, Adshead in as Ultimate Products chair
(Sharecast News) - Ultimate Products, the parent of homeware brands including Salter and Beldray, announced a change in its leadership on Monday, with James 'Jim' McCarthy deciding to step down as non-executive chair from 31 July.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.